NCT Number: NCT03769766
Phase: Phase 3
Trial Summary: This is a prospective study to determine if the use of curcumin randomized against placebo will reduce cancer progression in patients with prostate cancer undergoing active surveil – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): University of Texas Southwestern Medical Center
Acronym:
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives